AI Article Synopsis
Article Abstract
The reaction between the bisborate Li2[o-C6H4(BH3)2] and 2 equivalents of an appropriate pyrazole derivative (Hpz(R)) in the presence of Me3SiCl yields o-phenylene-bridged pyrazaboles HB(μ-pz(R))2(μ-o-C6H4)BH (3a-3e; Hpz(R) = 4-iodopyrazole (3a), 4-(trimethylsilyl)pyrazole (3b), 3,5-dimethylpyrazole (3c), 3,5-di(tert-butyl)pyrazole (3d), 3,5-bis(trifluoromethyl)pyrazole (3e)). The synthesis approach thus provides access to uncharged B-N triptycenes bearing (i) functionalisable groups, (ii) electron-donating or -withdrawing substituents and (iii) pyrazole rings of varying steric demand. Treatment of p-R*C6H4BBr2 with the potassium tris(pyrazol-1-yl)borates K[HBpz3] or K[p-R*C6H4Bpz3] yields cationic pyrazolyl-bridged pyrazaboles [p-BrC6H4B(μ-pz)3BH]Br ([4a]Br) and [p-R*C6H4B(μ-pz)3Bp-C6H4R*]Br (R* = Br ([4b]Br), I ([4c]Br), SiMe3 ([4d]Br)), which can be regarded as full B-N analogues of triptycene. The B-H bonds of 3b and [4a]Br are unreactive towards tBuC[triple bond, length as m-dash]CH even at temperatures of 80 °C, thereby indicating an appreciable thermal stability of the corresponding B-N cage bonds. Most of the cage compounds are sufficiently inert towards water to allow quick aqueous workup. However, NMR spectroscopy in CD3OD solution reveals degradation of 3b or [4a]Br to the corresponding pyrazoles and o-C6H4(B(OCD3)2)2 or p-BrC6H4B(OCD3)2/B(OCD3)3. The diphenylated species [4b]Br is significantly more stable under the same measurement conditions; even after 76 d, most of the material degrades only to the stage of the syn/anti-pyrazaboles p-BrC6H4(CD3O)B(μ-pz)2B(OCD3)p-C6H4Br (11a/11b). A derivatisation of [4c]Br with nBu3SnC≡CtBu through Stille-type coupling reactions furnishes the alkynyl derivative [p-tBuC≡CC6H4B(μ-pz)3Bp-C6H4C≡CtBu]Br ([4e]Br). Larger B-N aggregates are also accessible: treatment of the tetrakisborate Li4[1,2,4,5-C6H2(BH3)4] with 4 equivalents of Hpz(R) in the presence of Me3SiCl leads to the corresponding B-N pentiptycenes (Hpz(R) = 3,5-bis(trifluoromethyl)pyrazole (14a), 4-(trimethylsilyl)pyrazole (14b), 3,5-dimethylpyrazole (14c), 3,5-di(tert-butyl)pyrazole (14d)).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c4dt00442f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Significance of the Sparing Pronator Quadratus for Volar Plating of Distal Radius Fractures: A Prospective Study.
Cureus
November 2024
Orthopaedics, Gandhi Medical College, Bhopal, Bhopal, IND.
Background Pronator quadratus (PQ) acts as the pronator of the wrist and stabiliser of the distal radioulnar joint; it also provides a protective cover over the edge of the plate, preventing friction and subsequent rupture of flexor tendons. The repair of PQ is often difficult, and its durability is questionable; hence, preserving the PQ while volar plating distal radius fractures is advocated. Methods In this prospective randomised trial, 60 patients with a fracture of the distal end of the radius of AO-type (Arbeitsgemeinschaft für Osteosynthesefragen) 23 A2, A3, B1, B3, C1, and C2 were treated with volar plate fixation using either the PQ-releasing and repair approach (Group A, n = 30) or the PQ-sparing approach (Group B, n = 30), allowed by simple randomisation.
View Article and Find Full Text PDFNear-infrared phosphorescence in a ruthenium(II) complex equipped with a pyridyl-1,2-azaborine ligand.
Dalton Trans
December 2024
Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), Via Piero Gobetti 101, 40129 Bologna, Italy.
The 4-methyl-2-(pyridin-2-yl)-2,1-borazaronaphthalene molecule Hazab-py has been successfully used, for the first time, as a ligand in a ruthenium(II) polypyridine complex A (with the formula [Ru(dtbbpy)(azab-py)], where dtbbpy = 4,4'-di--butyl-2,2'-bipyridine). This compound was characterized by NMR spectroscopy and high-resolution mass spectrometry (MS), and its electrochemical and photophysical properties were fully investigated and compared to those of its homoleptic analogue [Ru(dtbbpy)] (B), an archetypical mono-cationic cyclometalated complex C (with the formula [Ru(dtbbpy)(ppy)], where Hppy = 2-phenylpyridine), and the more structurally similar analogue [Ru(dtbbpy)(naft-py)] (D), where the B-N unit of the azaborine ligand is replaced by a standard CC one, resulting in the 2-(naphthalen-2-yl)pyridine ligand (Hnaft-py). The presence of the novel 1,2-azaborine ligand induces a 0.
View Article and Find Full Text PDFAmmonia boranes and amine boranes are main group analogues of alkanes, which are characterised by their large gravimetric hydrogen content. This hydrogen can be released in dehydrocoupling and dehydropolymerisation reactions to obtain B-N oligomers and polymers that are of importance as precursors for functional B-N materials. Furthermore, amine boranes are potent reagents for application in transfer hydrogenation reactions, representing a versatile, easy-to-handle alternative to the use of gaseous hydrogen for the reduction of organic compounds.
View Article and Find Full Text PDFComparison of Clinical Outcomes Between Arthroscopic Rotator Cuff Repair and Reverse Total Shoulder Arthroplasty in Patients With Massive Rotator Cuff Tears and High-Grade Fatty Atrophy Without Glenohumeral Osteoarthritis.
Orthop J Sports Med
December 2024
Oregon Shoulder Institute, Medford, Oregon, USA.
Background: Despite the effectiveness of reverse total shoulder arthroplasty (RSA) and arthroscopic rotator cuff repair (ARCR) for treating massive rotator cuff tears (MRCTs), controversies remain in patients without glenohumeral osteoarthritis (GHOA).
Purpose: To compare clinical outcomes of ARCR or RSA in patients with MRCT with high-grade fatty atrophy without GHOA.
Study Design: Cohort study; Level of evidence, 3.
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial.
ESMO Open
December 2024
Department of Medical Oncology IMIBIC, Universidad de Córdoba, CIBERONC, Instituto de Salud Carlos III, Hospital Universitario Reina Sofía, Córdoba, Spain.
Background: The combination chemotherapy i.v. 5-fluorouracil (5-FU), irinotecan, and aflibercept (FOLFIRI-A) is a standard second-line treatment of metastatic colorectal cancer (mCRC).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!